Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinming Yu

Showing results (311-320 of 822) with videos related to

Pageof 83
Sort By:
Journal of Inflammation Research|September 16, 2024
Progressive Disease with Mixed Response After Immunotherapy in Non-Small Cell Lung CancerJuncai Lv, Weiwei Yan, Ran Zhang, et al.
Journal of Gastrointestinal Oncology|May 19, 2025
The highly expressed <i>GOLPH3</i> in colorectal cancer cells activates smoothened to drive glycolysis and promote cancer cell growth and radiotherapy resistanceKunli Zhu, Jing Fan, Hongchao Cai, et al.
BMC Public Health|May 15, 2025
Association of frailty and its trajectory with the risk of cancer: evidence from the China health and retirement longitudinal study (CHARLS)Qian Gao, Pengfei Li, Zhengyang Lu, et al.
Archivos De Bronconeumologia|June 21, 2024
Sex-specific Difference for Small Cell Lung Cancer from Immunotherapy AdvancementYou Mo, Yiwei Qin, Jian Shangguan, et al.
Heliyon|December 21, 2023
Pan-cancer analysis identifies protein arginine methyltransferases <i>PRMT1</i> and <i>PRMT5</i> and their related signatures as markers associated with prognosis, immune profile, and therapeutic response in lung adenocarcinomaJia Wang, Meng Wu, Jujie Sun, et al.
Lung Cancer (Amsterdam, Netherlands)|February 5, 2011
Prognostic significance of metabolic parameters measured by (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with small cell lung cancerDongyuan Zhu, Tinghang Ma, Zuoxing Niu, et al.
Medical Oncology (Northwood, London, England)|January 26, 2011
Prognostic value of Smac expression in rectal cancer patients treated with neoadjuvant therapyHongjiang Yan, Jinming Yu, Renben Wang, et al.
Technology in Cancer Research & Treatment|May 9, 2023
Patients with Lower Positive Lymph Nodes Ratio May Benefit from Preoperative Radiotherapy in Stage III Non-Small Cell Lung CancerRuiyang Wang, Shijie Shang, Xinyi Huang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 16, 2018
miR-608 and miR-4513 significantly contribute to the prognosis of lung adenocarcinoma treated with EGFR-TKIsNasha Zhang, Yankang Li, Yan Zheng, et al.
Cancer Science|July 14, 2007
Assessment of 11C-labeled-4-N-(3-bromoanilino)-6,7-dimethoxyquinazoline as a positron emission tomography agent to monitor epidermal growth factor receptor expressionHui Wang, Jinming Yu, Guoren Yang, et al.
Pageof 83

Showing results (311-320 of 822) with videos related to

Sort By:
Pageof 83
Journal of Inflammation Research|September 16, 2024
Progressive Disease with Mixed Response After Immunotherapy in Non-Small Cell Lung CancerJuncai Lv, Weiwei Yan, Ran Zhang, et al.
Journal of Gastrointestinal Oncology|May 19, 2025
The highly expressed <i>GOLPH3</i> in colorectal cancer cells activates smoothened to drive glycolysis and promote cancer cell growth and radiotherapy resistanceKunli Zhu, Jing Fan, Hongchao Cai, et al.
BMC Public Health|May 15, 2025
Association of frailty and its trajectory with the risk of cancer: evidence from the China health and retirement longitudinal study (CHARLS)Qian Gao, Pengfei Li, Zhengyang Lu, et al.
Archivos De Bronconeumologia|June 21, 2024
Sex-specific Difference for Small Cell Lung Cancer from Immunotherapy AdvancementYou Mo, Yiwei Qin, Jian Shangguan, et al.
Heliyon|December 21, 2023
Pan-cancer analysis identifies protein arginine methyltransferases <i>PRMT1</i> and <i>PRMT5</i> and their related signatures as markers associated with prognosis, immune profile, and therapeutic response in lung adenocarcinomaJia Wang, Meng Wu, Jujie Sun, et al.
Lung Cancer (Amsterdam, Netherlands)|February 5, 2011
Prognostic significance of metabolic parameters measured by (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with small cell lung cancerDongyuan Zhu, Tinghang Ma, Zuoxing Niu, et al.
Medical Oncology (Northwood, London, England)|January 26, 2011
Prognostic value of Smac expression in rectal cancer patients treated with neoadjuvant therapyHongjiang Yan, Jinming Yu, Renben Wang, et al.
Technology in Cancer Research & Treatment|May 9, 2023
Patients with Lower Positive Lymph Nodes Ratio May Benefit from Preoperative Radiotherapy in Stage III Non-Small Cell Lung CancerRuiyang Wang, Shijie Shang, Xinyi Huang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 16, 2018
miR-608 and miR-4513 significantly contribute to the prognosis of lung adenocarcinoma treated with EGFR-TKIsNasha Zhang, Yankang Li, Yan Zheng, et al.
Cancer Science|July 14, 2007
Assessment of 11C-labeled-4-N-(3-bromoanilino)-6,7-dimethoxyquinazoline as a positron emission tomography agent to monitor epidermal growth factor receptor expressionHui Wang, Jinming Yu, Guoren Yang, et al.
Pageof 83